Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. A caller asked whether the stock is a buy, sell, or hold. In response, Cramer said:
I like it here. I see so many IPOs every morning that Carl mentions, and they’re all going to need TMO’s machines. I think you can buy it at this level. I know at 19 times earnings, I’m surprised it is that cheap.
Photo by jason briscoe on Unsplash
Thermo Fisher Scientific Inc. (NYSE:TMO) provides instruments, reagents, consumables, software, and lab services that support scientific research, diagnostics, and drug and vaccine development. Cramer mentioned the stock during the April 23 episode, as he said:
Alright, what just happened to the stock of Thermo Fisher Scientific, the arms dealer to the life sciences industry that I’ve liked for so long? This morning, Thermo Fisher reported what looks like a very solid set of numbers, a modest revenue beat paired with a healthy 19-cent earnings beat off a $5.25 basis. Management also raised their full-year forecast substantially, but their guidance for the current quarter came in light. In response, the stock got obliterated today, plunging $47.28 or 9.2% to the point where the stock’s now down nearly 20%… I think that the market has this wrong… This is a great American company.
While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.